NEW YORK – Abbott Laboratories released data from an interim clinical study on Wednesday that confirmed the sensitivity and specificity of its ID Now COVID-19 rapid test.
NEW YORK – Abbott Laboratories released data from an interim clinical study on Wednesday that confirmed the sensitivity and specificity of its ID Now COVID-19 rapid test.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.